Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CytoChemia was a German pharmaceutical company based in Ihringen that specialized in immunotherapeutics and other physiologically oriented pharmaceutical products. The company appears to have marketed a portfolio of proprietary and in-licensed products and sold primarily to gynecologists, urologists, and oncologists. Historical sources also indicate that CytoChemia held German marketing rights for Striant SR, a testosterone replacement product for male hypogonadism. The company was part of a small affiliated group that included Holsten Pharma, Herbapharm, and PEGASUS pharma, with PEGASUS supporting parenteral manufacturing. Registry data indicate that CytoChemia AG entered liquidation in 2009 and was deleted from the commercial register in 2010.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CytoChemia.